NASDAQ:AZN

Astrazeneca Stock News

Healthcare > Drug Manufacturers - General

Buy AZN

*Your capital is at risk

$183.02

+2.00 (+1.10%)

At Close: Jun 24, 2026

Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against AstraZeneca PLC

12:30pm, Tuesday, 07'th Jan 2025

LOS ANGELES, CA / ACCESSWIRE / January 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca"

J&J says its lung cancer drug combination keeps people alive longer

10:59am, Tuesday, 07'th Jan 2025

Johnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year longer than AstraZeneca's Tagrisso in a clinical trial. J&J is trying to supp

AstraZeneca pipeline undervalued and underrated, broker suggests

09:31am, Tuesday, 07'th Jan 2025

AstraZeneca PLC (LSE:AZN) decline has gone too far, according to the analysts at Berenberg, who note that attention in 2025 switches to the breast cancer, hypertension and obesity pipelines. Currentl

J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug

08:10am, Tuesday, 07'th Jan 2025

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending lives of patients with a type of lung cancer, compared to AstraZeneca's block

Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN

07:30am, Tuesday, 07'th Jan 2025

NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol

AZN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Stockholders Have Opportunity to Lead Class Action Lawsuit!

07:00am, Tuesday, 07'th Jan 2025

NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AstraZeneca PL

AZN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

06:05am, Tuesday, 07'th Jan 2025

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Astrazeneca business and prospects, resulting in its stock trading at inflated prices.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZN

05:45am, Tuesday, 07'th Jan 2025

NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINIT

Levi & Korsinsky Notifies Shareholders of AstraZeneca PLC(AZN) of a Class Action Lawsuit and an Upcoming Deadline

08:20pm, Monday, 06'th Jan 2025

NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol

ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

08:00pm, Monday, 06'th Jan 2025

NEW ORLEANS, LA / ACCESSWIRE / January 6, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until Febru

AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN

04:30pm, Monday, 06'th Jan 2025

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by